NITROLINGUAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nitrolingual, and when can generic versions of Nitrolingual launch?
Nitrolingual is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in NITROLINGUAL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitrolingual
A generic version of NITROLINGUAL was approved as nitroglycerin by AM REGENT on May 24th, 1988.
Summary for NITROLINGUAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,886 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NITROLINGUAL |
| What excipients (inactive ingredients) are in NITROLINGUAL? | NITROLINGUAL excipients list |
| DailyMed Link: | NITROLINGUAL at DailyMed |
See drug prices for NITROLINGUAL
Recent Clinical Trials for NITROLINGUAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United States Naval Medical Center, San Diego | Phase 2 |
| University of Zurich | Phase 4 |
Pharmacology for NITROLINGUAL
| Drug Class | Nitrate Vasodilator |
| Physiological Effect | Vasodilation |
US Patents and Regulatory Information for NITROLINGUAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pohl Boskamp | NITROLINGUAL | nitroglycerin | AEROSOL;SUBLINGUAL | 018705-001 | Oct 31, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pohl Boskamp | NITROLINGUAL PUMPSPRAY | nitroglycerin | SPRAY, METERED;SUBLINGUAL | 018705-002 | Jan 10, 1997 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for NITROLINGUAL
See the table below for patents covering NITROLINGUAL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2718345 | PREPARATION PHARMACEUTIQUE A GRANDE STABILITE, CONTENANT LE PRINCIPE ACTIF TRINITRATE DE GLYCEROL (LONG-TERM STABLE PHARMACEUTICAL PREPARATION HAVING THE ACTIVE INGREDIENT GLYCEROL TRINITRATE) | ⤷ Try a Trial |
| Hungary | T58515 | ⤷ Try a Trial | |
| World Intellectual Property Organization (WIPO) | 2009112258 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
